Study guide
4.2 Compression Therapy Protocols & ABI Safety Cutoffs
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
4.2 Compression Therapy Protocols & ABI Safety Cutoffs
Key Takeaways Explain This Topic AI
Baseline Ankle-Brachial Index (ABI) determines compression safety: ABI ≥ 0.80 allows full high compression (30–40 mmHg), ABI 0.50–0.79 permits modified reduced compression (20–30 mmHg), and ABI < 0.50 strictly contraindicates compression.
An ABI > 1.30 indicates arterial calcification, requiring secondary testing with Toe-Brachial Index (TBI ≥ 0.70) or TcPO2 (> 40 mmHg) before applying compression.
According to Laplace's Law (P = (T × N × 4620) / (C × W)), sub-bandage pressure increases with higher wrap tension or added layers, and decreases as limb circumference increases.
Short-stretch compression wraps exert low resting pressure and high working pressure, rendering them safe for ambulatory patients and mild arterial compromise, whereas long-stretch wraps exert high resting pressure and low working pressure.
Compression therapy is the cornerstone of healing venous leg ulcers (CEAP C5–C6) and preventing ulcer recurrence (CEAP C4–C5 maintenance with 20–30 mmHg or 30–40 mmHg stockings).
Last updated: August 2026
Compression Therapy Protocols & ABI Safety Cutoffs
Compression therapy represents the gold-standard therapeutic intervention for lower extremity venous disease, chronic venous insufficiency (CVI), and venous leg ulcers (VLUs). By applying external therapeutic pressure to the lower leg, compression counteracts ambulatory venous hypertension, reduces microvascular extravasation, restores lymphatic drainage, and accelerates epithelialization in chronic venous wounds.
Pathophysiology of Venous Hypertension & Compression Mechanics
Chronic venous insufficiency stems from incompetence of superficial, deep, or perforating venous valves, or from deep vein outflow obstruction (post-thrombotic syndrome). Under normal ambulation, calf muscle contraction compresses deep veins, propelling venous blood superiorly toward the heart while functioning valves prevent retrograde reflux. When valves fail, muscle contraction forces high-pressure venous blood backward into superficial capillaries. This persistent ambulatory venous hypertension triggers:
- Extravasation of erythrocytes into interstitial tissue (hemosiderin staining)
- Pericapillary fibrin cuff formation, impairing oxygen and nutrient diffusion
- Leukocyte entrapment and inflammatory tissue necrosis, culminating in venous ulceration (CEAP class C6)
- Hemodynamic Effects of External Compression
Venous Diameter Reduction: Compressing superficial and deep veins reduces lumen cross-sectional area, directly increasing venous blood flow velocity ( Q = V × A Q = V \times A Q = V × A ).
Valvular Coaptation: Decreasing vein lumen diameter allows damaged valve leaflets to meet, reducing retrograde reflux.
Edema Evacuation: Increases interstitial hydrostatic pressure, driving fluid back into lymphatic capillaries and microvasculature.
Physics of Compression: Laplace's Law & Graduated Pressure
The mechanical sub-bandage pressure delivered to a limb is governed by Laplace's Law , expressed in the sub-bandage pressure equation: P = T × N × 4620 C × W P = \frac{T \times N \times 4620}{C \times W} P = C × W T × N × 4620
Where:
- P = Sub-bandage pressure (mmHg) P = \text{Sub-bandage pressure (mmHg)} P = Sub-bandage pressure (mmHg)
- T = Bandage tension (kgf) T = \text{Bandage tension (kgf)} T = Bandage tension (kgf)
N = Number of applied bandage layers N = \text{Number of applied bandage layers} N = Number of applied bandage layers
- C = Limb circumference (cm) C = \text{Limb circumference (cm)} C = Limb circumference (cm)
- W = Bandage width (cm) W = \text{Bandage width (cm)} W = Bandage width (cm)
- Clinical Implications of Laplace's Law
Anatomical Graduation: Because calf circumference ( C C C ) is larger than ankle circumference, applying a bandage with constant tension ( T T T ) naturally generates a graduated pressure profile —highest at the narrow ankle and decreasing proximally toward the wider calf.
Conical Shaping & Padding: In thin, bony legs with small ankle circumferences, unpadded compression produces excessively high sub-bandage pressures over bony prominences (malleoli, tibial crest), risking tissue necrosis. Padding must be applied to smooth the limb shape into a uniform cone.
Vascular Safety Screening & ABI Compression Cutoffs
Applying high compression to a limb with unrecognized peripheral artery disease (PAD) can cause total arterial occlusion, ischemic tissue necrosis, and limb amputation. Baseline vascular evaluation using the Ankle-Brachial Index (ABI) is mandatory prior to applying any compression system.
ABI Range Perfusion Status Compression Protocol & Safety Guideline
> 1.30 Non-Compressible / Calcified Medial arterial calcinosis (Mönckeberg's). Perform TBI (≥ 0.70) or TcPO2 (> 40 mmHg) before applying compression.
0.91 – 1.30 Normal Arterial Perfusion Full High Compression (30–40 mmHg) safe. Standard protocol for uncomplicated venous leg ulcers.
0.80 – 0.90 Mild Arterial Disease Full Compression (30–40 mmHg) allowed with clinical monitoring of distal capillary refill and sensation.
0.50 – 0.79 Moderate Arterial Disease Modified Reduced Compression (20–30 mmHg) indicated. Use short-stretch or multi-layer reduced compression; monitor closely.
< 0.50 Severe PAD / CLTI Compression Strictly Contraindicated! Urgent vascular surgical referral required for revascularization.
Compression Systems & Wrap Mechanics
Compression modalities are categorized by their elastic extensibility, which dictates their resting pressure (pressure exerted when the patient is recumbent) and working pressure (pressure generated during calf muscle contraction).
- 1. Inelastic / Short-Stretch Wraps (e.g., Comprilan, Unna Boot)
- Extensibility: < 100 % < 100\% < 100%
Mechanics: Low resting pressure (comfortable while lying down); high working pressure (provides a rigid wall against contracting calf muscles, propelling venous blood upward during walking).
Indications: Mobile, ambulatory patients; patients with mixed arterial-venous disease (ABI 0.50–0.79); severe edema.
- 2. Elastic / Long-Stretch Wraps (e.g., ACE Bandages, High-Elastic Single Wraps)
- Extensibility: > 100 % > 100\% > 100%
Mechanics: High resting pressure; low working pressure. Yields under muscular expansion during ambulation.
Precautions: High resting pressure can cause arterial ischemia at night when the limb is horizontal. Must be removed before bed unless part of a multi-layer system.
3. Multi-Layer Compression Bandage Systems (4LB / 2LB)
Composition: Combines padding (layer 1), light stretch (layer 2), short-stretch (layer 3), and cohesive elastic wrap (layer 4).
Mechanics: Delivers sustained 30–40 mmHg pressure at the ankle for up to 7 days in ambulatory and non-ambulatory patients with normal ABI.
4. Compression Hosiery (Medical Stockings)
Class I (15–20 mmHg): Mild edema, spider veins, heavy legs.
Class II (20–30 mmHg): Varicose veins, mild CVI, post-ulcer healing maintenance (CEAP C4–C5), modified compression for mixed disease.
Class III (30–40 mmHg): Severe CVI, active or healed venous ulcers (CEAP C5–C6), lymphedema.
Class IV (40–50 mmHg): Severe refractory lymphedema.
- System Type Resting Pressure Working Pressure ABI Requirement Primary Clinical Indication
- Multi-Layer 4LB System High (sustained) High ABI ≥ 0.80 Active Venous Leg Ulcers (CEAP C6)
Short-Stretch Wrap Low (safe supine) High (during walk) ABI 0.50–0.79 or ≥ 0.80 Mixed disease, edema, ambulatory VLUs
- Unna Boot (Zinc Paste) Low Very High ABI ≥ 0.80 Ambulatory VLUs with severe weeping
- Long-Stretch Single Wrap Very High Low ABI ≥ 0.80 Short-term superficial edema support
- Class III Hosiery (30–40 mmHg) High Moderate ABI ≥ 0.80 VLU Recurrence Prevention (CEAP C5)